← Back to catalogue

IDG/Sanzay

FDA UDI

Class II (US FDA UDI)

by IDG/SANZAY Corporation

Identity

Trade Name
IDG/Sanzay FDA UDI
Generic Name
Conjugated (direct) bilirubin IVD, reagent FDA UDI
Device Name
For the quantitative determination of direct bilirubin in human serum. For in vitro diagnostic use. FDA UDI
Model / Reference
1 FDA UDI
Description
For the quantitative determination of direct bilirubin in human serum. For in vitro diagnostic use. FDA UDI

Identifiers

Catalog Number
C071 FDA UDI
Primary DI / UDI-DI
00850053916045 FDA UDI
510(k) Number
K881172 FDA UDI
FDA Product Code
CIG FDA UDI
GMDN Term
Conjugated (direct) bilirubin IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1110 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 100 Milliliter FDA UDI
Total Volume — 240 Milliliter FDA UDI
Total Volume — 1 Liter FDA UDI
Total Volume — 250 Milliliter FDA UDI
Total Volume — 480 Milliliter FDA UDI

Category: Conjugated (direct) bilirubin IVD, reagent

IDG/Sanzay by IDG/SANZAY Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Conjugated (direct) bilirubin IVD, reagent.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 41e866ca-af00-4605-bbcc-0e6a983fb077 37 fields · synced Jun 8, 2026